MarketBeat | Real-Time Financial News and Analysis

Open Main Menu Open Sidebar

Avalanche Biotechnologies Company Profile (NASDAQ:AAVL)

Consensus Ratings for Avalanche Biotechnologies (NASDAQ:AAVL) (?)
Ratings Breakdown: 3 Hold Rating(s), 3 Buy Rating(s)
Consensus Rating:Buy (Score: 2.50)
Consensus Price Target: $37.83 (136.02% upside)

Analysts' Ratings History for Avalanche Biotechnologies (NASDAQ:AAVL)
Show:
DateFirmActionRatingPrice TargetActions
6/23/2015Chardan CapitalUpgradeSell -> Neutral$20.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
6/17/2015Piper JaffrayReiterated RatingOverweight$52.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
6/17/2015Cowen and CompanyReiterated RatingOutperform$55.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
6/17/2015SunTrustLower Price TargetBuy -> Neutral$60.00 -> $25.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
6/16/2015Chardan CapitalDowngradeNeutral -> Sell$40.00 -> $20.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
6/16/2015SunTrustDowngradeBuy -> Neutral$60.00 -> $25.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
6/16/2015Jefferies GroupReiterated RatingBuy$51.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
6/16/2015William BlairDowngradeOutperform -> Market Perform$53.00 -> $24.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
6/3/2015Piper JaffrayReiterated RatingOverweight$52.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/23/2015Jefferies GroupReiterated RatingBuy$51.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/15/2015Piper JaffrayReiterated RatingOverweight$52.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
3/26/2015Jefferies GroupBoost Price TargetBuy$46.00 -> $51.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
3/26/2015Chardan CapitalReiterated RatingHold$40.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
3/26/2015Piper JaffrayBoost Price TargetOverweight$52.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
3/9/2015SunTrustInitiated CoverageBuy$60.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
3/9/2015Piper JaffrayReiterated RatingOverweight$47.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
2/19/2015Chardan CapitalInitiated CoverageNeutral$40.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
2/13/2015Jefferies GroupBoost Price TargetBuy$40.00 -> $46.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
12/2/2014Piper JaffrayBoost Price Target$47.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
8/25/2014William BlairInitiated CoverageOutperform$52.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
8/25/2014Cowen and CompanyInitiated CoverageOutperform$45.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
8/25/2014Piper JaffrayInitiated CoverageOverweight$39.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
8/25/2014Jefferies GroupInitiated CoverageBuy$40.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
(Data available from 7/5/2013 forward)